Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey

References

• Kendler KS, Gallagher TJ, Abelson JM, et al. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996; 5311: 1022–1031
   Google Scholar
• Goldner EM, Hsu L, Waraich P, et al. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry 2002; 479: 833–843
   Google Scholar
• Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005; 66: 1122–1129
   PubMed Web of Science ®Google Scholar
• McEvoy JP. The costs of schizophrenia. J Clin Psychiatry 2007; 68(Suppl 14)4–7
   PubMed Web of Science ®Google Scholar
• Masand PS. Differential pharmacology of atypical antipsychotics: clinical implications. Am J Health Syst Pharm 2007; 64(2 Suppl 1)S3–8
   Google Scholar
• Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892–909
   PubMed Web of Science ®Google Scholar
• Valenstein M, Ganoczy D, McCarthy JF, et al. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry 2006; 67: 1542–1550
   PubMed Web of Science ®Google Scholar
• Cooper D, Moisan J, Gregoire JP. Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia. J Clin Psychiatry 2007; 68: 818–825
   PubMed Web of Science ®Google Scholar
• Morken G, Widen JH, Grawe RW. Non-adherence to antipsychotic medication, relapse and rehospitalization in recent-onset schizophrenia. BMC Psychiatry 2008; 8: 32
   PubMed Web of Science ®Google Scholar
• Law MR, Soumerai SB, Ross-Degnan D, et al. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry 2008; 69: 47–53
   PubMed Web of Science ®Google Scholar
• Sun SX, Liu GG, Christensen DB, et al. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin 2007; 23: 2305–2312
   PubMed Web of Science ®Google Scholar
• Piette JD, Heisier M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care 2004; 27: 384–391
   PubMed Web of Science ®Google Scholar
• Doshi JA, Zhu J, Lee BY, et al. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation 2009; 119: 390–397
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Patrick AR, Maclure M, et al. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation 2007; 115: 2128–2135
   PubMed Web of Science ®Google Scholar
• Curkendall S, Patel V, Gleeson M, et al. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?. Arthritis Rheum 2008; 59: 1519–1526
   PubMed Web of Science ®Google Scholar
• Hirth RA, Greer SL, Albert JM, et al. Out-of-pocket spending and medication adherence among dialysis patients in twelve countries. Health Aff (Millwood) 2008; 27: 89–102
   PubMed Web of Science ®Google Scholar
• Hartung DM, Carlson MJ, Kraemer DF, et al. Impact of a Medicaid copayment policy on prescription drug and health service utilization in a fee-for-service Medicaid population. Med Care 2008; 46: 565–572
   PubMed Web of Science ®Google Scholar
• Zeber JE, Grazier KL, Valenstein M, et al. Effects of medication copayment increase in veterans with schizophrenia. Am J Manage Care 2007; 13: 335–346
   PubMed Web of Science ®Google Scholar
• Rosenheck R, Leslie D, Keefe R, et al. Barriers to employment for people with schizophrenia. Am J Psychiatry 2006; 163: 411–417
   PubMed Web of Science ®Google Scholar
• Salkever DS, Karakus MC, Slade EP, et al. Measures and predictors of community-based employment and earnings of persons with schizophrenia in a multisite study. Psychiatr Serv 2007; 58: 15–24
   Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74
   PubMed Web of Science ®Google Scholar
• Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004; 38: 1363–1368
   PubMed Web of Science ®Google Scholar
• Revicki DA, Leidy NK, Howland L. Evaluating the psychometric characteristics of the Psychological General Well-Being Index with a new response scale. Qual Life Res 1996; 5: 419–425
   PubMed Web of Science ®Google Scholar
• Dupuy HJ. The psychological general well-being index. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, NK Wenger, ME Mattson, CD Fuberg, J Elinson. LeJacq, New York 1984
   Google Scholar
• MacKinnon DP, Dwyer JH. Estimating mediated effects in prevention studies. Eval Rev 1993; 17: 144–158
   Web of Science ®Google Scholar
• Swartz MS, Stroup TS, McEvoy JP, et al. What CATIE found: results from the schizophrenia trial. Psychiatr Serv 2008; 59: 500–506
   PubMed Web of Science ®Google Scholar
• Jones PB, Barnes TR, Davies L, et al. Randomized controlled trial of the effects on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006; 63: 1079–1087
   PubMed Web of Science ®Google Scholar
• Kim E, Levy R, Pikalov A. Personalized treatment with atypical antipsychotic medications. Advan Ther 2007; 24: 721–740
   PubMed Web of Science ®Google Scholar
• Huskamp HA. Managing psychotropic drug costs: will formularies work?. Health Aff (Millwood) 2006; 22: 84–96
   Google Scholar